Biomedical research and development has consequences not only for health and health care spending, but also social surplus and economic development. This collection of papers was initiated by a conference with the leadership of the National Institutes of Health on June 1, 2005 held at the RAND Corporation offices in Washington D.C. The editors of the Forum for Health Economics and Health Policy invite further submissions on this topic.

Volume 9 - Issue 2 (2006)